Annals of Movement Disorders (Jan 2022)

Hemifacial spasm responsive to single low-dose abobotulinumtoxin A in a patient with relapsing-remitting multiple sclerosis: A case report

  • Julie Ann Kristy L Torres,
  • Meliza Angelica J de Leon,
  • Raymond L Rosales

DOI
https://doi.org/10.4103/AOMD.AOMD_48_21
Journal volume & issue
Vol. 5, no. 2
pp. 118 – 120

Abstract

Read online

Hemifacial spasm (HFS) is a movement disorder characterized by involuntary twitching of the facial muscles of one side of the face. Here, we report the case of a 31-year-old woman with relapsingremitting multiple sclerosis who presented with left-sided HFS while receiving interferon beta. Despite immunosuppressive medications and clonazepam, only a partial response was documented. Near complete resolution of HFS was achieved 6 months after a single low dose of abobotulinumtoxin A was injected into the left periocular muscles; no recurrence was observed after 4 years. Botulinum toxin injection for focal dystonia, such as HFS, may lead to long-term symptomatic benefit in patients with multiple sclerosis who have already received optimum medical treatment.

Keywords